More Men Than Women With Parkinson's Have Caregivers

Share this content:
More Men Than Women With Parkinson's Have Caregivers
More Men Than Women With Parkinson's Have Caregivers

TUESDAY, Dec. 5, 2017 (HealthDay News) -- For patients with Parkinson's disease (PD), more men than women have a caregiver, and greater strain is reported for caregivers of men, according to a study published online Dec. 1 in Neurology.

Nabila Dahodwala, M.D., from the University of Pennsylvania in Philadelphia, and colleagues compared access to caregiving between men and women with PD in a cross-sectional and longitudinal study. A total of 7,209 PD patients (63 percent men and 37 percent women) were evaluated.

The researchers found that the mean age was 66.0 for men and 66.9 for women. Compared with women, more men had a caregiver (88.4 versus 79.4 percent; P < 0.0001), and caregivers of men reported greater strain (Multidimensional Caregiver Strain Index score, 19.9 versus 16.4; P < 0.0001). After controlling for age, disease stage, number of comorbidities, cognitive and mobility measures, and health-related quality of life, these differences persisted. Compared to men, women had lower odds of caregiver accompaniment at baseline visit (odds ratio, 0.76); women also had a faster rate to using a paid caregiver (hazard ratio, 1.76) after adjustment for confounding variables.

"Informal caregiving resources are lower for women than men with PD, despite the finding that their caregivers report less strain than those of men. In addition, women are more likely to use formal, paid caregivers," the authors write. "Strategies to improve access to caregiving, particularly for women, are needed."

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A&#43;AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »